LTRN
LTRN
NASDAQ · Biotechnology

Lantern Pharma Inc

$0.46
-0.02 (-4.24%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +5,540.5% upside
Low Target $20.93
Average Target $25.98
High Target $39.39
Current Price $0.46
Current
$0.46
Target
$25.98
$20.93 $25.98 avg $39.39
Scenario Analysis
Bear Case
$20.93
4,444.1%
Low target
Base Case
$25.98
+5,540.5%
Avg target
Bull Case
$39.39
+8,451.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.34
-89.4% from high
52-Week Low
$0.52
+-11.4% from low
Target vs 52W High
$25.98
+498.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%